1. Home
  2. PTHL vs ZBAI Comparison

PTHL vs ZBAI Comparison

Compare PTHL & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • ZBAI
  • Stock Information
  • Founded
  • PTHL 1998
  • ZBAI 2015
  • Country
  • PTHL China
  • ZBAI United States
  • Employees
  • PTHL N/A
  • ZBAI N/A
  • Industry
  • PTHL
  • ZBAI Professional Services
  • Sector
  • PTHL
  • ZBAI Consumer Discretionary
  • Exchange
  • PTHL Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • PTHL 10.0M
  • ZBAI 10.8M
  • IPO Year
  • PTHL 2024
  • ZBAI N/A
  • Fundamental
  • Price
  • PTHL $0.63
  • ZBAI $8.38
  • Analyst Decision
  • PTHL
  • ZBAI
  • Analyst Count
  • PTHL 0
  • ZBAI 0
  • Target Price
  • PTHL N/A
  • ZBAI N/A
  • AVG Volume (30 Days)
  • PTHL 111.6K
  • ZBAI 92.5K
  • Earning Date
  • PTHL 01-01-0001
  • ZBAI 11-12-2025
  • Dividend Yield
  • PTHL N/A
  • ZBAI N/A
  • EPS Growth
  • PTHL N/A
  • ZBAI N/A
  • EPS
  • PTHL N/A
  • ZBAI N/A
  • Revenue
  • PTHL $448,196.00
  • ZBAI $720,000.00
  • Revenue This Year
  • PTHL N/A
  • ZBAI N/A
  • Revenue Next Year
  • PTHL N/A
  • ZBAI N/A
  • P/E Ratio
  • PTHL N/A
  • ZBAI N/A
  • Revenue Growth
  • PTHL N/A
  • ZBAI 44.00
  • 52 Week Low
  • PTHL $0.51
  • ZBAI $4.83
  • 52 Week High
  • PTHL $32.00
  • ZBAI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • PTHL 31.21
  • ZBAI 49.26
  • Support Level
  • PTHL $0.55
  • ZBAI $7.54
  • Resistance Level
  • PTHL $0.70
  • ZBAI $10.88
  • Average True Range (ATR)
  • PTHL 0.06
  • ZBAI 0.66
  • MACD
  • PTHL 0.09
  • ZBAI -0.23
  • Stochastic Oscillator
  • PTHL 29.13
  • ZBAI 24.25

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: